These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31061148)

  • 1.
    Grupper M; Stainton SM; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061148
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Abdelraouf K; Stainton SM; Nicolau DP
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061165
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Gupta A; Malik S; Kaminski M; Landman D; Quale JM
    Microb Drug Resist; 2022 Apr; 28(4):419-424. PubMed ID: 35451880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.
    Cohen Stuart J; Leverstein-Van Hall M; Kortmann W; Verlind J; Mulder F; Scharringa J; Fluit A; Ekkelenkamp M
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):2021-2025. PubMed ID: 30117050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favourable effect of clavulanic acid on the minimum inhibitory concentrations of cefixime and ceftibuten in ESBL-producing Escherichia coli and Klebsiella pneumoniae.
    Martinez-Guerra BA; Xancal-Salvador LF; Esteban-Kenel V; Tello-Mercado AC; Bobadilla-Del-Valle M; Sifuentes-Osornio J; Ponce-de-Leon A; Gonzalez-Lara MF
    J Glob Antimicrob Resist; 2024 Sep; 38():212-215. PubMed ID: 38945364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of Ceftibuten: An Assessment of an Oral Cephalosporin against Enterobacterales in a Neutropenic Murine Thigh Model.
    Lasko MJ; Asempa TE; Nicolau DP
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33669512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
    Rossi B; Soubirou JF; Chau F; Massias L; Dion S; Lepeule R; Fantin B; Lefort A
    Antimicrob Agents Chemother; 2016 Jan; 60(1):424-30. PubMed ID: 26525800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rapid detection of extended-spectrum beta-lactamases by flow cytometry method].
    Duyan S; Kılıç A; Yılmaz S; Ardıç N
    Mikrobiyol Bul; 2015 Oct; 49(4):600-8. PubMed ID: 26649418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combination.
    Fratoni AJ; Avery LM; Nicolau DP; Asempa TE
    J Antimicrob Chemother; 2022 Dec; 78(1):93-100. PubMed ID: 36272135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
    Livermore DM; Hope R; Mushtaq S; Warner M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():189-93. PubMed ID: 18154546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics/Pharmacodynamics Evaluation of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli In Vitro and In Vivo in a Murine Thigh Infection Model.
    Tashiro S; Hayashi M; Takemura W; Igarashi Y; Liu X; Mizukami Y; Kojima N; Enoki Y; Taguchi K; Yokoyama Y; Nakamura T; Matsumoto K
    Pharm Res; 2021 Jan; 38(1):27-35. PubMed ID: 33404990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an
    VanScoy BD; Tenero D; Turner S; Livermore DM; McCauley J; Conde H; Bhavnani SM; Rubino CM; Ambrose PG
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
    Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging clinical role of pivmecillinam in the treatment of urinary tract infections caused by Extended Spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    Int J Clin Pract; 2019 Sep; 73(9):1-5. PubMed ID: 31243859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.
    Stewart AG; Harris PNA; Henderson A; Schembri MA; Paterson DL
    J Antimicrob Chemother; 2020 Sep; 75(9):2384-2393. PubMed ID: 32443141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.